Basket

  1. 1.
    0542237 - BTÚ 2022 RIV GB eng J - Journal Article
    Ezrová, Zuzana - Nahácka, Zuzana - Štursa, Jan - Werner, Lukáš - Vlčák, Erik - Kralova Viziova, Petra - Berridge, M.V. - Sedláček, Radislav - Zobalová, Renata - Rohlena, Jakub - Boukalová, Štěpána - Neužil, Jiří
    SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy.
    Oncogene. Roč. 40, č. 14 (2021), s. 2539-2552. ISSN 0950-9232. E-ISSN 1476-5594
    R&D Projects: GA MZd(CZ) NV16-31604A; GA ČR GA19-20553S; GA ČR(CZ) GA20-18513S; GA ČR(CZ) GJ20-11724Y; GA ČR(CZ) GA18-02550S; GA MŠk(CZ) EF16_027/0008353; GA MŠk(CZ) ED1.1.00/02.0109; GA MŠk LO1220; GA MŠk(CZ) LM2015062; GA MŠk(CZ) EF16_013/0001775; GA MŠk(CZ) LM2018126; GA MŠk EF16_013/0001789; GA MŠk EF18_046/0015861; GA MŠk ED2.1.00/19.0395
    Research Infrastructure: CESNET - 90005
    Institutional support: RVO:86652036 ; RVO:68378050
    Keywords : biguanide derivative * reduced nicotinamide adenine dinucleotide dehydrogenase (ubiquinone) * Smad4 protein
    OECD category: Genetics and heredity (medical genetics to be 3); Genetics and heredity (medical genetics to be 3) (UMG-J)
    Impact factor: 9.867, year: 2020
    Method of publishing: Limited access
    https://www.nature.com/articles/s41388-021-01726-4?elqTrackId=c7cc7e8c0df94ff7a61453bf09cfb167
    Permanent Link: http://hdl.handle.net/11104/0319702